Results 301 to 310 of about 67,891 (311)

Drug–lactose binding aspects in adhesive mixtures: Controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces

Advanced Drug Delivery Reviews, 2012
Qi Zhou, David Av Morton, Qi Tony Zhou
exaly  

Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial

Lancet Respiratory Medicine,the, 2013
Mitesh Patel, Janine Pilcher, Alison Pritchard   +2 more
exaly  

Efficacy and Safety of Budesonide and Formoterol in One Pressurized Metered-Dose Inhaler in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Drugs, 2012
Donald P Tashkin, Stephen I Rennard
exaly  

Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease

Drugs, 2012
Stephen I Rennard, Donald P Tashkin, Philip Silkoff   +2 more
exaly  

Inhaler competence in asthma: Common errors, barriers to use and recommended solutions

Respiratory Medicine, 2013
David B Price
exaly  

Importance of inhaler devices in the management of airway disease

Respiratory Medicine, 2008
Peter J Barnes
exaly  

Pharmacotherapy for Nicotine Dependence

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Alternative carriers in dry powder inhaler formulations

Drug Discovery Today, 2014
Yahya Rahimpour, Maryam Kouhsoltani, Hamed Hamishehkar   +2 more
exaly  

Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review

Npj Primary Care Respiratory Medicine, 2017
Sven L Klijn, Silvia M A A Evers, Thys van der Molen   +2 more
exaly  

Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis

Asian Journal of Pharmaceutical Sciences, 2018
A Sudheer, Eranti Bhargav
exaly